Assignee
OLARIS INC
US·1 granted patent·5 pending applications·0 citations·filing 2019–2025
Top patents by PatentIndex Score
6 records- 0159US2023087439A1Nmr-Metabolite-Signature For Identifying Cancer Patients Resistant To Cdk4/6 Inhibitors, Endocrine Therapy and Anti-HER2 TherapyOLARIS INC·Filed 2022·Application pending·0 cites
- 0252US2025258159A1Device, method and system for monitoring immune system responseOLARIS INC·Filed 2025·Application pending·0 cites
- 0351US2020116657A1Nmr-metabolite-signature for identifying cancer patients resistant to cdk4/6 inhibitors, endocrine therapy and anti-her2 therapyOLARIS INC·Filed 2019·Application pending·0 cites
- 0451US2022326224A1Spectographic Metabolite-Signature for Identifying a Subject's Susceptibility to DrugsOLARIS INC·Filed 2022·Application pending·0 cites
- 0548US11366102B2Spectographic metabolite-signature for identifying a subject's susceptibility to drugsOLARIS INC·Filed 2019·Granted Jun 21, 2022·0 cites·19 claims
- 0646US2022276224A1Device, method and system for monitoring immune system responseOLARIS INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →